NEW ORLEANS — In low-risk patients with atrial fibrillation for whom anticoagulation therapy would be indicated, device-based left atrial appendage closure (LAAC) was about equal to non-vitamin K antagonist oral anticoagulant (NOAC) therapy in preventing serious cardiovascular events. However, whether the procedure is an alternative for NOAC therapy to reduce stroke risk is an open question. LAAC ...